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Abstract
Introduction: Due to highly active antiretroviral therapy (HAART), HIV-1 infection has evolved from a lethal to a chronic disease.
As such, health-related quality of life (HRQoL) has become an important outcome variable. The purpose of this study was to
identify socio-economic, behavioural, (neuro)psychological and clinical determinants of HRQoL among people living with HIV
(PLHIV).
Methods: This study was conducted between 1 January and 31 December 2012 at the AIDS Reference Centre of Ghent University
Hospital, a tertiary care referral centre in Belgium. Validated self-report questionnaires were administered to collect socio-
demographic data, to assess HRQoL (Medical Outcomes Study-HIV), depressive symptoms (Beck Depression Inventory-II) and
adherence to HAART (Short Medication Adherence Questionnaire) and to screen for neurocognitive dysfunction.
Results: A total of 237 people participated, among whom 187 (78.9%) were male. Mean age was 45.8910.7 years and 144
(63.7%, 144/226) participants were homosexual. Median physical and mental health score (PHS, MHS) were 55.6 (IQR 48.2
60.6) and 52.0 (IQR 44.257.9), respectively. Multivariable regression analysis revealed that incapacity to work, depressive
symptoms, neurocognitive complaints (NCCs), dissatisfaction with the patientphysician relationship and non-adherence were
all negatively associated with HRQoL.
Conclusions: Socio-economic (work status), behavioural (adherence) and (neuro)psychological (depressive symptoms, NCCs)
determinants independently impact HRQoL among this cohort of PLHIV. Clinical parameters (viral load, CD4 cell count) were not
independently associated with HRQoL.
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Introduction
In Belgium, 12,600 people living with HIV (PLHIV) are
medically followed, and there is a stable incidence rate of
three new diagnoses per day [1]. Highly active antiretroviral
therapy (HAART) therapy is reimbursed by health insurance,
and more than 80% of the people on HAART have an
undetectable viral load [2]. Worldwide, similar significant
improvements in virological control through HAART emerge,
and HIV has developed into a chronic disease with reason-
able life expectancy [3]. Hence, the prevalence of PLHIV still
increases [4]. As a result, concerns about lifelong medication
use as well as physical and mental consequences of a chronic
illness became important outcome indicators. In HIV treat-
ment decisions, the impact on health-related quality of life
(HRQoL) is a particular point of interest [5]. Maximizing
HRQoL is a key goal in HIV care and, therefore, it is necessary
to identify which factors influence HRQoL. Changing or
managing these factors by means of targeted interventions
should be the focus of healthcare managers and policy
makers.
Studies investigating determinants of HRQoL found asso-
ciations with clinical [69], socio-economic [1012], psycho-
logical [1316] and behavioural [1720] parameters. Those
studies mostly examined a specific and limited set of para-
meters within their field of interest. However, few studies
[2123] evaluated parameters from different categories
simultaneously and none of them included neuropsychologi-
cal parameters. As such, the possible distinctive influence of
neurocognitive problems on HRQoL remains unclear.
This study is the first to investigate HRQoL in Belgium, and
the first to incorporate neuropsychological parameters in a
broad and detailed set of possible determinants of HRQoL.
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Methods
Setting
The study was conducted at the AIDS Reference Centre of
Ghent University Hospital (GUH), one of nine tertiary care
referral centres in Belgium involved in the medical treatment
and emotional and social support for PLHIV. One thousand
three-hundred PLHIV are currently followed by a multi-
disciplinary team of physicians, (social) nurses, psychologists
and psychiatrists. The collaborating AIDS Reference Labora-
tory is responsible for HIV diagnosis (serology, viral load,
resistance, genotyping) and data collection of blood values.
Participants
To obtain a representative sample of the HIV population seen
in the ARC, all PLHIV consulting the ARC during the study
period were eligible to participate. There were no constraints
concerning age, time since diagnosis, treatment or other
variables. Treating physicians recruited participants during a
routine patient visit via informed consent, available in Dutch,
French and English. The study was approved by the Ethics
Committee of GUH and recruitment of participants started
on 1 January 2012.
Instruments
Patients were asked to fill in a self-developed and validated
self-report questionnaire and to participate in a short inter-
view with a nurse. Socio-demographic and socio-economic
questions, as well as three validated instruments (Medical
Outcomes Study-HIV  MOS-HIV, Short Medication Adher-
ence Questionnaire  SMAQ and Beck Depression Inventory-
II  BDI-II) were incorporated in the bundle.
To evaluate HRQoL, the MOS-HIV [24] was used. This
instrument contains 35 items, which lead to 11 subscale
scores between 0 and 100 (health perceptions, pain, physical
functioning, social functioning, role functioning, mental fun-
ctioning, energy, cognitive functioning, health distress, qua-
lity of life and health transition). Two final scores are then
calculated: the physical health score (PHS) and the mental
health score (MHS).
In addition, participants were asked to fill in the six-item
SMAQ [25] and the 21-item BDI-II [26]. Presence of depres-
sive symptoms in people with chronic illnesses is defined as a
score of 17 or more on the BDI-II [27].
In a short interview with a nurse, the patients answered
three questions to screen for the presence of neurocognitive
complaints (NCCs) [28]. Memory, planning and attention pro-
blems were surveyed. One or more ‘‘yes’’ answers are indi-
cative for NCCs.
Clinical data were obtained through the electronic patient
file.
Analyses
Data were analyzed using the statistical software package
SPSS, version 21 (SPSS, Inc., Chicago, IL). Categorical variables
are reported as numbers and percentages, continuous vari-
ables as medians and interquartile ranges (IQR) since they
were non-normally distributed. PHS and MHS were separately
analyzed as continuous, dependent variables. For bivariate
analysis, MannWhitney U tests and KruskalWallis tests
were used and correlations were calculated. Multivariable
linear regression analysis was conducted to potentially
identify determinants independently associated with HRQoL.
Every variable with a p50.20 after bivariate analysis was put
into a multivariable linear regression model. Backward
conditional procedures were performed manually to identify
independent determinants. These were sequentially put into
a model, based on the enter procedure. Significance of the
covariates is reported by the p-values, parameter estimates by
the unstandardized coefficients (B) and 95% confidence
intervals (CI). Goodness of fit was reported by the R2 of the
model. Statistical significance was set at p50.05.
Results
Population
A total of 237 PLHIV participated in the study. Malefemale
ratio was 4:1, mean age was 45.8910.7 years and 63.7%
(144/226) of the participants were homosexual. Almost
90% (209/237) were Caucasian and 69.2% (164/237) were
employed.
At the time of assessment, the vast majority (92.0%, 218/
237) was receiving HAART, and viral load and CD4 cell count
wereB40 copies/ml and 500 cells/ml in 74.3% (176/237)
and 59.9% (142/237) of participants, respectively.
Depressive symptoms were observed in 22.3% (51/229) of
the participants and 86 participants (36.3%) had NCCs.
In this sample, there is an underrepresentation of black
PLHIV as compared to the PLHIV seen in the centre (10% vs.
24%) and of people with foreign origin as compared to the
total Belgian cohort (10% vs. 49%). Male-to-female ratio is
higher than the ratio in the total Belgian cohort (4 vs. 1.7).
Mean age in the study sample (45.8 years) is higher than
mean age of PLHIV seen in the centre (44.1 years) and mean
age of the total Belgian cohort (43.1 years).
Population characteristics, also disaggregated by gender,
are available as Supplementary file.
Quality of life
Median PHS and MHS are 55.6 (IQR 48.260.6) and 52.0 (IQR
44.257.9), respectively. PHS is significantly higher than MHS
(pB0.001, Table 1) and there is a significant correlation
between them (0.644; pB0.01). The median scores on the
subscales, for men and women, are shown in Table 1.
Table 2 shows the results of the bivariate analysis. A lower
PHS and MHS is seen in PLHIV who are female (pB0.001
and 0.006), not working (seeking work B0.001 and 0.048,
househusband/housewife 0.021 and 0.015, invalid both
B0.001), living alone (p0.003 and B0.001) and having an
income Bt1.500 (both pB0.001). Lower PHS and MHS are
also associated with shorter time since diagnosis (p0.017
and 0.040), the presence of depressive symptoms (both
pB0.001), NCCs (both pB0.001), less satisfaction with rela-
tionship with physician (p0.049 and 0.004), dissatisfac-
tion with social support (both pB0.001), dissatisfaction with
sex life (both pB0.001) and poor adherence (both pB0.001).
Black ethnicity (p0.030) and dissatisfaction with infor-
mation received about medication (p0.010) are associ-
ated with lower PHS, whereas not being married (divorced
p0.006, single B0.001) and drug use (p0.021) are
associated with lower MHS (Table 2).
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Multivariable linear regression analysis shows that the
presence of depressive symptoms, NCCs, work incapacity,
satisfaction with the patientphysician relationship and non-
adherence are independently associated with both poor PHS
and MHS. Seeking work and being a househusband/house-
wife negatively influence PHS. Dissatisfaction with sex life is
associated with lower MHS (Table 3).
Discussion
PHS and MHS of the MOS-HIV in this cohort of PLHIV are high
and comparable to those found in HIV patients studied in
other countries [10,21,2931]. Scores on the subscales
of the MOS-HIV are even comparable to those found in a
general healthy population, except for a lower score for
mental health [32]. The good clinical status of our cohort
and the high representation of white gay men might be a
potential explanation. In people with other chronic diseases
such as chronic fatigue syndrome or rheumatoid arthritis,
substantially lower HRQoL scores have been reported [32,33].
It seems that HIV does not interfere with daily life to the same
extent as these other chronic diseases.
Determinants associated with a lower HRQoL in this study
are the presence of depressive symptoms, NCCs, working
situation, satisfaction with the relationship with the physi-
cian, adherence and satisfaction with sex life.
It is well known that depressive symptoms negatively
impact perceived HRQoL [16,23,34,35]. In this study, depres-
sive symptoms were independently associated with both
poor MHS and PHS. Moreover, depressive symptoms inter-
fere with all domains as measured by the subscales of the
MOS-HIV (except health transition), which emphasizes their
considerable impact. Systematic and periodic screening for
depression, as well as an appropriate treatment if necessary,
is imperative to intervene in this prominent problem.
NCCs were found to be independently associated with
lower PHS, MHS and lower subscale scores (except health
transition). Neurocognitive impairment has already been
shown to be a predictor of poor HRQoL [36] and to be sig-
nificantly associated with lower scores on all HRQoL subscales
[37].This might be explained by difficulties in coping with daily
activities such as stocking, managing their money, planning
appointments and so on, which potentially lead to frustration
and a loss of independence [36]. Medical professionals, family
members and PLHIV themselves should be vigilant for these
signs. Screening and prevention of HIV-associated neurocog-
nitive disorder should become more familiar in HIV care to
determine effective treatment strategies (exclude neurotoxi-
city if possible, treating co-morbidity, etc.) [38].
We could not, however, confirm the presence of NCCs by a
neurocognitive testing battery, but it was previously ob-
served that patient-reported measures of neurocognitive
functioning and results on objective neurocognitive testing
correlate significantly [37].
Several studies report that employed PLHIV tend to have
better HRQoL [10,12,3941]. Employment has an important
role in the daily life of people. It provides structure, a social
support network, role identity and meaning [40]. Physical
functioning, role functioning, social functioning, pain, mental
health and health distress were found to be significantly
affected by disability. Differences in physical health as com-
pared to employed people were also observed in job seekers.
They have lower scores in physical-, role-, and social fun-
ctioning and energy.
The exact association between employment and HRQoL
remains unproven. This is possibly a bi-directional relation-
ship [10,12]. PLHIV with good HRQoL can choose to work
(selection hypothesis), or work can be a source of wellbeing
(causation hypothesis) [10]. Working should be encouraged
and therefore possible internal or external barriers should be
addressed [42]. PLHIV could be advised by peers, medical
professionals and HR- and labour legislation experts about
their rights and about practical concerns and discomforts. Our
research group, in collaboration with the Flemish expertise
centre on sexual health, currently gathers experiences from
PLHIV at the workplace. This is a first step in developing a
framework for employers and employees to inform them and
to guide them through HIV at the workplace.
The importance of a good patientphysician relationship is
emphasized by its contribution to both physical and mental
health. It was shown that a good and trustful patient
physician relationship contributes to a good adherence
[43,44] and to an undetectable viral load [44]. Mental health
improves by the feeling of ‘‘being treated as a person’’ and
trust in the physician [44,45]. The perception of empathy and
a good knowledge about HIV seem to be predictive for
satisfaction about the patientphysician relationship [46].
Physicians should be aware of this and invest in their
relationship with PLHIV.
Furthermore, adherence itself influences HRQoL. Differ-
ences between adherent versus non-adherent participants
are seen in all subscales of the MOS-HIV, which corresponds
with the overall conclusion of the review on this topic by
Geocze, Mucci, De Marco, Nogueira-Martins and Cicero [20].
Table 1. Results of MOS-HIV: quality of life scores for men and
women
Median (IQR)
Men Women
Total scores
Physical health score 57.7 (49.660.9) 51.4 (44.254.5)
Mental health score 52.8 (45.158.7) 50.4 (41.654.9)
Subscales
General health perceptions 70 (5085) 63.9 (4575)
Physical functioning 91.7 (75100) 75 (5083.33)
Role functioning 100 (100100) 100 (50100)
Social functioning 100 (80100) 80 (60100)
Cognitive functioning 80 (65100) 75 (65100)
Pain 88.9 (66.67100) 77.8 (55.56100)
Mental health 72 (5680) 65.20 (5676)
Energy 70 (5580) 60 (4575)
Health distress 85 (65100) 70 (5090)
Quality of life 75 (5075) 75 (5075)
Health transition 50 (5075) 67.1 (5075)
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Table 2. Results of bivariate analyses (Mann-Whitney U test, KruskalWallis test or Pearson correlation)
Variable PHS (median and IQR) p MHS (median and IQR) p
Sex B0.001 0.006
Female 51.37 (44.1954.52) 50.37 (41.6454.95)
Male 57.65 (49.6060.95) 52.83 (45.0958.74)
Sexual orientation (n226) 0.066 0.155
Heterosexual 53.29 (44.5659.60) 50.80 (43.0956.40)
Homosexual 57.65 (49.6561.21) 53.02 (45.2958.71)
Bisexual 54.40 (44.6459.13) 44.94 (41.1053.54)
Age (correlation) 0.115 0.076 0.092 0.158
Ethnicity (n236) 0.030 0.680
White 57.16 (49.2660.87) 52.57 (44.1558.09)
Black 52.27 (44.3957.41) 50.52 (45.8955.90)
Viral load 0.651 0.238
B50 copies/ml 56.53 (48.2260.92) 51.92 (45.1257.99)
40400 copies/ml 53.75 (49.5558.93) 51.53 (43.9056.47)
4011000 copies/ml 54.98 (45.7459.08) 59.49 (54.6962.54)
1000 copies/ml 55.65 (45.6060.91) 51.87 (41.1055.90)
CD4 cell count 0.112 0.602
B200 45.87 (38.4253.06) 52.93 (47.8059.87)
200500 55.66 (47.5360.23) 50.94 (44.1556.16)
500 56.42 (49.7060.87) 53.33 (44.2458.19)
ART treatment 0.464 0.602
No 54.01 (47.7458.47) 52.42 (44.2557.92)
Yes 56.10 (48.2360.73) 50.99 (39.5058.13)
Time since diagnosis (correlation) 0.155 0.017 0.133 0.040
Depressive symptoms B0.001 B0.001
No 57.69 (51.9960.95) 54.69 (50.2658.89)
Yes 47.82 (39.2453.37) 39.76 (34.3444.00)
Civil status 0.095 0.003
Married 58.68 (53.7161.41) 55.56 (49.9560.13)
Cohabitant 57.17 (48.2160.87) 52.88 (43.3860.71)
Divorced 53.06 (45.9959.08) 50.52 (45.1254.82)
Widow/widower 56.54 (51.2660.22) 44.45 (37.8452.99)
Alone 53.74 (47.5359.96) 50.52 (42.2956.13)
Domestic situation 0.003 B0.001
Living with partner/children,
family or friends 57.71 (50.5260.90) 53.47 (46.9659.85)
Living alone 53.24 (47.0859.66) 50.37 (41.9655.75)
Place of residence 0.414 0.674
At home 56.21 (48.2160.75) 52.20 (44.0757.95)
Others 53.06 (48.9057.74) 50.52 (50.2555.50)
Children 0.086 0.184
No 57.24 (49.2960.91) 52.75 (44.1958.40)
Yes 53.06 (44.5859.45) 50.52 (45.0455.52)
Education 0.525 0.161
Primary school (12 years) 53.06 (44.1958.60) 50.52 (41.7859.19)
College (15 years) 53.06 (46.8159.47) 50.52 (43.9055.03)
College (18 years) 57.23 (48.2360.87) 52.80 (45.5460.13)
College of higher education (3 years) 55.47 (50.2160.73) 51.84 (45.8955.90)
College of higher education (3 years) 58.87 (49.9362.06) 51.95 (39.9957.93)
University 57.04 (52.9659.08) 55.81 (46.8158.34)
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Table 2 (Continued )
Variable PHS (median and IQR) p MHS (median and IQR) p
Activity B0.001 B0.001
Student 52.25 (44.1955.52) 49.77 (45.8954.06)
Working 58.37 (53.0661.24) 53.90 (48.9858.65)
Job seeker 49.30 (42.8155.58) 47.05 (39.9957.73)
Housewife/househusband 43.05 (34.7657.99) 45.24 (34.4450.49)
Invalid 40.90 (34.8149.88) 41.43 (35.9645.69)
Retired 57.70 (51.6558.66) 57.58 (47.8060.71)
Income (after taxes) (n226) B0.001 B0.001
Bt 1500 52.41 (41.6758.74) 48.66 (40.6655.51)
]t 1500 57.95 (53.0661.29) 54.26 (48.7958.87)
Smoking 0.816 0.200
No 58.89 (49.3059.91) 52.61 (45.2158.29)
Yes 54.57 (46.2861.05) 51.11 (42.9556.73)
Drug use 0.072 0.021
No 56.89 (49.2660.75) 52.78 (45.2058.09)
Yes 50.66 (45.4459.13) 48.41 (38.8353.63)
Alcohol use 0.075 0.112
No 54.44 (47.5360.29) 50.52 (43.9357.07)
53/day 58.19 (49.8861.29) 55.22 (45.7559.19)
3/day 57.72 (45.1259.07) 52.22 (37.1657.73)
Religion 0.350 0.857
Atheist 57.58 (50.9360.75) 52.83 (44.1958.19)
Catholic 57.04 (48.2360.87) 51.79 (44.2558.19)
Protestant 50.80 (48.1054.52) 52.80 (46.0155.50)
Muslim 53.06 (51.0963.49) 55.90 (50.5256.40)
Others 53.70 (45.4159.96) 48.66 (43.9057.60)
Membership self-help group 0.585 0.248
No 55.66 (48.2360.54) 52.57 (44.2458.02)
Yes 53.06 (45.9959.83) 49.31 (44.9851.25)
Satisfaction relationship physician 0.049 0.004
Very satisfied 56.81 (49.3160.80) 53.02 (45.1658.62)
Satisfied or indifferent 50.93 (45.4158.96) 46.64 (39.8853.70)
Satisfied information medication (n221) 0.010 0.558
No 49.55 (41.3057.98) 50.25 (40.4259.65)
Yes 57.10 (49.3360.87) 52.49 (45.0957.92)
Satisfaction support B0.001 B0.001
(Very) Satisfied 57.64 (50.2560.93) 53.52 (46.6458.69)
(Very) unsatisfied or indifferent 49.65 (42.0457.18) 44.88 (35.9650.94)
Satisfaction sex life B0.001 B0.001
(Very) satisfied 58.39 (53.0661.22) 55.47 (50.4959.85)
(Very) unsatisfied or indifferent 51.09 (44.5857.69) 45.54 (38.5852.81)
Neurocognitive complaints B0.001 B0.001
No 58.25 (51.6561.32) 55.41 (49.8359.87)
Yes 50.72 (44.2056.10) 45.72 (39.6151.79)
SMAQ adherent (n218) B0.001 B0.001
No 49.70 (44.1953.32) 48.41 (39.7452.72)
Yes 57.74 (50.8061.07) 53.47 (45.8958.87)
Median and IQR are shown for categorical variables, the correlation coefficient for continuous variables.
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Out of 12 studies, 10 showed a positive association between
adherence and HRQoL. A causal relationship was, however,
not clear. Adherence to ART could lead to better HRQoL,
considering the protective role of ART in disease progression
and mortality. However, ART frequently causes serious side
effects (e.g. nausea, diarrhoea, lipodystrophy), which of
course negatively influence HRQoL. Some PLHIV may there-
fore feel the tendency to stop adhering to ART in an attempt
to re-establish their HRQoL. Another possibility could be
that adherence and HRQoL have overlapping determinants.
However, it is evident that adherence remains a highly im-
portant goal and moreover, interventions to improve ad-
herence could have additional HRQoL benefits.
PLHIV who are satisfied about their sex life have a higher
MHS than those who are not. In the literature, studies
addressing this relationship are scarce. Most research dis-
cusses sexual dysfunction rather than sexual satisfaction [47].
However, there is evidence that a good sex life contributes
to good HRQoL in the general population [48] and that
experiencing sexual problems is associated with poorer
quality of life in gay men [49]. In our study, dissatisfaction
with sex life is associated with significant lower scores on all
subscales of the MOS-HIV except health transition. Appar-
ently, multiple domains of HRQoL are influenced by this
presently understudied outcome measure.We recommend to
break the taboo about sexual problems and to take these
complaints seriously. They can be the expression of multiple
stressors: for example, troubles in the current relationship,
loneliness, trauma and physical causes. Accurate identifica-
tion of the cause(s) should lead to the right treatment
approach [50].
There are several study limitations that need to be
addressed. The number of participants is limited. Never-
theless, good predictive models for HRQoL were achieved
and the number is considered as adequate given the great
detail in our research. A second limitation is the self-report of
depressive symptoms and NCCs. Formal testing by a
psychiatrist or neuropsychologist was not done. Because of
the cross-sectional design, we were not able to determine
causal relationships. Furthermore, taking into account the
non-normal PHS and MHS, linear regression analysis reveals
less correct models than median regression analysis would
do. Our study results can also not be generalized to the
population of PLHIV in Belgium, as our sample included an
Table 3. Multivariable linear regression models for PHS and MHS
p B [95% Confidence Interval]
PHS model
Constant B0.001 56.04 [53.48; 58.60]
Depressive symptoms 0.017 3.19 [6.62; 1.75]
Work situation
Student (vs. working) 0.158 5.88 [14.07; 2.31]
Seeking work (vs. working) 0.001 6.54 [10.50; 2.58]
Househusband/housewife (vs. working) 0.017 8.74 [15.90; 1.58]
Invalid (vs. working) B0.001 11.70 [14.74; 8.67]
Retired (vs. working) 0.084 3.47 [7.0; 0.47]
Neurocognitive complaints 0.007 2.88 [4.981; 0.788]
Satisfaction with relation physician 0.028 2.85 [0.31; 5.40]
Non-adherence 0.001 4.18 [6.62; 1.75]
R20.426
MHS model
Constant B0.001 51.34 [49.01; 53.675]
Depressive symptoms B0.001 10.10 [12.22; 7.98]
Work situation
Student (vs. working) 0.153 4.74 [11.25; 1.77]
Seeking work (vs. working) 0.517 1.04 [4.20; 2.12]
Househusband/housewife (vs. working) 0.650 1.32 [7.03; 4.39]
Invalid (vs. working) B0.001 5.90 [8.34; 3.45]
Retired (vs. working) 0.873 0.26 [3.39; 2.88]
Neurocognitive complaints B0.001 4.46 [6.15; 2.77]
Satisfaction with sex life B0.001 3.29 [1.64; 4.95]
Satisfaction with relation physician B0.001 3.80 [1.77; 5.82]
Non-adherence B0.001 3.61 [5.56; 1.67]
R20.653
MHS, mental health score; PHS, physical health score.
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overrepresentation of gay men, Belgian and older PLHIV.
Finally, the use of separate models for physical and mental
health may be artificial, regarding the evidence about a
strong, bi-directional relationship between them [51]. In fact,
in this study, physical and mental health were found to be
influenced by mainly the same parameters.
Behind these limitations, some strengths of this pilot study
should be considered. To the best of our knowledge, this
study is the first to investigate HRQoL among PLHIV in
Belgium. Moreover, in addition to clinical variables, whose
relationship with HRQoL has been the focus of a limited
number of studies [6,52,53], many other (socio-economic,
behavioural and psychological) variables were analyzed and
were found to be associated with HRQoL. Calling more
attention to non-clinical parameters in HIV care seems to be
a relevant approach.
Conclusions
PHS is high in this cohort of PLHIV. Not the clinical, but socio-
economic (working), behavioural (adherence, sex life) and
(neuro)psychological (depressive symptoms, NCCs) variables
significantly influence HRQoL, as well as the perceived quality
of the patientphysician relationship. Future research should
focus on interventions to improve HRQoL, in hospital settings
(supporting adherence, screening for and treating depression
and neurocognitive problems, improving patientphysician
relationship) and abroad (framework for HIV at the work-
place, promoting sexual health).
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